Hermed Capital
Overview
Hermed Capital is a private equity and venture capital firm that invests in the global healthcare industry, focusing on the pharmaceuticals, medical device and diagnostic, and medical services sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Prognos Health | Nov 2017 | Series C | Co-investor |
| Epic Sciences | Apr 2017 | Series D | Lead |
| Spineology | Sep 2017 | Convertible Debt | Co-investor |
| ABM Therapeutics | Jan 2022 | Series B | Co-investor |
| Shanghai Bendao Gene Technology | Jun 2023 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Hermed Capital based?
Hermed Capital is headquartered in Shanghai, China.
When was Hermed Capital founded?
Hermed Capital was founded in 2014.
How many portfolio companies does Hermed Capital have?
Hermed Capital has 5 portfolio companies in Caplight's dataset.
What are some companies in Hermed Capital's portfolio?
Portfolio companies visible on Caplight include Prognos Health, Epic Sciences, Spineology, ABM Therapeutics, Shanghai Bendao Gene Technology.
What was Hermed Capital's most recent investment shown here?
Hermed Capital's most recent investment in this portfolio sample was in Shanghai Bendao Gene Technology in 2023.
What sectors does Hermed Capital focus on?
Hermed Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software.
What company stages does Hermed Capital focus on?
Stage focus information for Hermed Capital is not publicly available.